02150nam 2200373 450 991068818240332120230704134155.0(CKB)5850000000050204(NjHacI)995850000000050204(EXLCZ)99585000000005020420230704d2022 uy 0engur|||||||||||txtrdacontentcrdamediacrrdacarrierAntiphospholipid syndrome recent advances in clinical and basic aspects /edited by Polona ŽigonLondon, England :IntechOpen,2022.1 online resource (142 pages)1-83969-055-0 Antiphospholipid syndrome (APS) is an acquired autoimmune disorder in which the immune system mistakenly produces antiphospholipid antibodies that attack tissues in the body. These antibodies can lead to the formation of blood clots in arteries and veins. During pregnancy, APS can also lead to miscarriage and stillbirth. Classification criteria require a clinical event (i.e., thrombosis or pregnancy complication) and persistent positive blood test results at least three months apart that detect lupus anticoagulant, anti-cardiolipin antibodies, or anti-β2-glycoprotein-1 antibodies. This book addresses important clinical aspects of APS, including stroke and APS, obstetric manifestations of APS, and bleeding complications in APS. It also discusses the diagnostic utility of a novel autoantibody against β2-glycoprotein I/HLA class II complexes as a promising biomarker for APS. Finally, this book also reviews the latest findings in the field of extracellular vesicles in APS and provides explanations of their role in the pathogenesis of APS.Antiphospholipid Syndrome Autoimmune diseasesAntiphospholipid syndromeAutoimmune diseases.Antiphospholipid syndrome.616.07/9Žigon PolonaNjHacINjHaclBOOK9910688182403321Antiphospholipid Syndrome1551273UNINA